EUVIMEDSkopri EUVIMED
Open access · CC BY-NC 4.0

Reproductive outcomes in women with Hodgkin's lymphoma in a Danish fertility preservation cohort

Lotte Berdiin Colmorn iD, Elisabeth C Larsen, Anette Tønnes Pedersen iD, Stine Gry Kristensen, Kirsten Tryde Macklon

Acta Obstetricia et Gynecologica Scandinavica · 2026-08 · 105 (8) · 1587-1596

DOI: 10.1111/aogs.70228 ↗

At a glance

Journal article in Acta Obstetricia et Gynecologica Scandinavica, published online on 2026-05-29. Written by Lotte Berdiin Colmorn and 4 co-authors. Institution: Fertility Clinic, Department of Gynecology, Fertility and Obstetrics, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark. Major MEDLINE topics: Hodgkin Disease, Fertility Preservation, Primary Ovarian Insufficiency, Antineoplastic Combined Chemotherapy Protocols. 24 references. The full text is freely available (open access, CC BY-NC 4.0).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Introduction

The risk of premature ovarian insufficiency (POI) after Hodgkin's lymphoma depends on female age, type, and dose of gonadotoxic treatment. Treatment with ABVD rarely results in POI and impaired fertility, whereas treatment with BEACOPP or stem cell transplantation is associated with higher risks of ovarian failure. Reports on parenthood rates are reassuring, although some studies report reduced fertility after treatment. In this study, we evaluate the reproductive outcomes after Hodgkin's lymphoma and the risk of POI after different types of chemotherapy. Material and Methods This cohort study was conducted at the Fertility Clinic at Rigshospitalet University Hospital, Copenhagen, Denmark. Data was collected retrospectively from medical records from 1999 to 2020 and prospectively from 2020 to 2023. We included all female patients with Hodgkin's lymphoma, referred for fertility preservation between 1999 and 2022. End of follow‐up was December 31, 2023. Information about diagnoses, gonadotoxic treatment, and gynecologic and obstetric history was retrieved from medical records.

Results

A total of 59 women were included: 21 received low‐dose, 15 moderate‐dose, and 20 high‐dose chemotherapy (3 unknown). Ovarian tissue cryopreservation (OTC) was done for fertility preservation in 86%. Mean age at diagnosis was 23.9 (SD 4.9) years. While no women developed POI after low‐dose chemotherapy, 4 (27%) did after moderate‐dose and 10 (50%) after high‐dose chemotherapy. Among 38 women with a pregnancy wish, 30 achieved at least one livebirth after cancer. Mean age at first pregnancy was 29.7 (SD 4.0) years. The chance of delivery after high dose was lower compared with low‐dose chemotherapy (OR 0.06, 95% CI:0.01–0.68) ( p = 0.020). Among 33 women with OTC, 21 achieved pregnancy and delivery without ovarian tissue transplantation (OTT). Nine women underwent OTT of whom four delivered (44%) a total of five children.

Conclusions

The likelihood of livebirth and risk of POI depended on the type of chemotherapy, with the least number of deliveries and the highest risk of POI after high‐dose chemotherapy. Pregnancy rates were reassuringly high even among women with a single ovary after OTC, with only 20% returning for OTT. Our findings support that fertility preservation in Hodgkin's lymphoma patients should primarily be offered to those receiving moderate‐ to high‐dose chemotherapy.

Subjects

MeSH terms (MEDLINE)

Hodgkin DiseaseFertility PreservationPrimary Ovarian InsufficiencyAntineoplastic Combined Chemotherapy ProtocolsHumansFemaleDenmarkPregnancyAdultRetrospective StudiesCryopreservationYoung AdultCohort StudiesOvaryPregnancy Outcome

Author keywords

Hodgkin diseaseadultantineoplastic combined chemotherapy protocolsbirth ratefemalefertility preservationpregnancyprimary ovarian insufficiency

Authors and institutions

  • Fertility Clinic, Department of Gynecology, Fertility and Obstetrics, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Gynecological Department, Department of Gynecology, Fetility and Obstetrics, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Laboratory for Reproductive Biology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.

ORCID profiles: Lotte Berdiin Colmorn, Anette Tønnes Pedersen

Cite

APA

Colmorn, L. B., Larsen, E. C., Pedersen, A. T., Kristensen, S. G., & Macklon, K. T. (2026). Reproductive outcomes in women with Hodgkin's lymphoma in a Danish fertility preservation cohort. Acta Obstetricia et Gynecologica Scandinavica, 105(8), 1587-1596. https://doi.org/10.1111/aogs.70228

Vancouver

Colmorn LB, Larsen EC, Pedersen AT, Kristensen SG, Macklon KT. Reproductive outcomes in women with Hodgkin's lymphoma in a Danish fertility preservation cohort. Acta Obstetricia et Gynecologica Scandinavica. 2026;105(8):1587-1596. doi:10.1111/aogs.70228

BibTeX
@article{Colmorn2026,
  author = {Colmorn, Lotte Berdiin and Larsen, Elisabeth C and Pedersen, Anette Tønnes and Kristensen, Stine Gry and Macklon, Kirsten Tryde},
  title = {Reproductive outcomes in women with Hodgkin's lymphoma in a Danish fertility preservation cohort},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  volume = {105},
  number = {8},
  pages = {1587--1596},
  doi = {10.1111/aogs.70228}
}
Start for free →